Role of major histocompatibility complex class I molecules in autoimmune myositis

Current Opinion in Rheumatology

Volumn 17, Issue 6, 2005, Pages 725-730

  Nagaraju, Kanneboyina ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune response; Endoplasmic reticulum stress response; Major histocompatibility complex class I; Myositis

Indexed keywords

AUTOANTIGEN; BETA 2 MICROGLOBULIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCAGON RECEPTOR; GLUCOSE REGULATED PROTEIN 78; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INSULIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; AUTOIMMUNITY; CELL DAMAGE; CELL FUNCTION; CELL REGENERATION; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; HUMAN; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOSITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; STRESS; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; AUTOIMMUNE DISEASES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MYOSITIS;

EID: 27544466638     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000179947.58271.9a     Document Type: Review

References (54)

1. Lundberg IE. Idiopathic inflammatory myopathies: why do the muscles become weak? Curr Opin Rheumatol 2001; 13:457-460.
2. Nagaraju K. Update on immunopathogenesis in inflammatory myopathies. Curr Opin Rheumatol 2001; 13:461-468.
3. Targoff IN. Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol 2000; 12:475-481.
4. Miller FW, Waite KA, Biswas T, Plotz PH. The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. Proc Natl Acad Sci U S A 1990; 87:9933-9937.
5. Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991; 70:360-374.
6. Hohlfeld R, Engel AG. The immunobiology of muscle. Immunol Today 1994; 15:269-274.
7. Nagaraju K, Cox A, Casciola-Rosen L, Rosen A. Novel fragments of the Sjogren's syndrome autoantigens alpha-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death. Arthritis Rheum 2001; 44:2376-2386.
8. DeVere R, Bradley WG. Polymyositis: its presentation, morbidity and mortality. Brain 1975; 98:637-666.
9. Engel AG, Arahata K. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 1986; 17:704-721.
10. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies, III: immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann Neurol 1986; 19:112-125.
11. Goebels N, Michaelis D, Engelhardt M, et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest 1996; 97:2905-2910.
12. Cherin P, Herson S, Crevon MC, et al. Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis. J Rheumatol 1996; 23:1135-1142.
13. Natali PG, Bigotti A, Nicotra MR, et al. Distribution of human Class I (HLA-A, B, C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res 1984; 44:4679-4687.
14. Singer DS, Maguire JE. Regulation of the expression of class I MHC genes. Crit Rev Immunol 1990; 10:235-257.
15. Gleimer M, Parham P. Stress management: MHC class I and class I-like molecules as reporters of cellular stress. Immunity 2003; 19:469-477.
16. Paulsson K, Wang P. Chaperones and folding of MHC class I molecules in the endoplasmic reticulum. Biochim Biophys Acta 2003; 1641:1-12.
17. Paulsson KM, Wang P. Quality control of MHC class I maturation. FASEB J 2004; 18:31-38.
18. Bouvier M. Accessory proteins and the assembly of human class I MHC molecules: a molecular and structural perspective. Mol Immunol 2003; 39:697-706.
19. Lilley BN, Ploegh HL. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 2004; 429:834-840.
20. Ye Y, Shibata Y, Yun C, et al. A membrane protein complex mediates retrotranslocation from the ER lumen into the cytosol. Nature 2004; 429:841-847.
21. Foulis AK, Farquharson MA, Hardman R. Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30:333-343.
22. Hanafusa T, Pujol-Borrell R, Chiovato L, et al. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 1983; 2:1111-1115.
23. Bottazzo GF, Dean BM, McNally JM, et al. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985; 313:353-360.
24. McDouall RM, Dunn MJ, Dubowitz V. Expression of class I and class II MHC antigens in neuromuscular diseases. J Neurol Sci 1989; 89:213-226.
25. Allison J, Campbell IL, Morahan G, et al. Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature 1988; 333:529-533.
26. Frauman AG, Chu P, Harrison LC. Nonimmune thyroid destruction results from transgenic overexpression of an allogeneic major histocompatibility complex class I protein. Mol Cell Biol 1993; 13:1554-1564.
27. Turnley AM, Morahan G, Okano H, et al. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature 1991; 353:566-569.
28. Nagaraju K, Raben N, Merritt G, et al. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol 1998; 113:407-414.
29. Hohlfeld R, Engel AG. HLA expression in myoblasts. Neurology 1991; 41:2015.
30. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 1989; 20:224-231.
31. Appleyard ST, Dunn MJ, Dubowitz V, Rose ML. Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders. Lancet 1985; 1:361-363.
32. Bartoccioni E, Gallucci S, Scuderi F, et al. MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin Exp Immunol 1994; 95:166-172.
33. Karpati G, Pouliot Y, Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 1988; 23:64-72.
34. Higuchi I, Nerenberg M, Ijichi T, et al. Vacuolar myositis with expression of both MHC class I and class II antigens on skeletal muscle fibers. J Neurol Sci 1991; 106:60-66.
35. van der PJ, Hengstman GJ, Ter Laak HJ, et al. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry 2004; 75:136-139. Study suggests that detection of sarcolemmal MHC is a valid diagnostic test for inflammatory myopathies.
36. Wiendl H, Behrens L, Maier S, et al. Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G. Ann Neurol 2000; 48:679-684.
37. Nagaraju K, Raben N, Loeffler L, et al. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A 2000; 97:9209-9214.
38. Tajima Y, Moriwaka F, Tashiro K. Temporal alterations of immunohistochemical findings in polymyositis. Intern Med 1994; 33:263-270.
39. Nagaraju K, Raben N, Villalba ML, et al. Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells. Clin Immunol 1999; 92:161-169.
40. Englund P, Nennesmo I, Klareskog L, Lundberg IE. Interleukin-1 alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue. Arthritis Rheum 2002; 46:1044-1055.
41. Nyberg P, Wikman AL, Nennesmo I, Lundberg I. Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J Rheumatol 2000; 27:940-948.
42. Dalakas MC. Immunopathogenesis of inflammatory myopathies. Ann Neurol 1995; 37(suppl 1):S74-S86.
43. Pavlath GK. Regulation of class I MHC expression in skeletal muscle: deleterious effect of aberrant expression on myogenesis. J Neuroimmunol 2002; 125:42-50.
44. Nagaraju K, Casciola-Rosen L, Lundberg I, et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 2005; 52:1824-1835. This study demonstrates that endoplasmic reticulum overload (NF-kB) and unfolded protein response pathways are highly activated in human myositis and in the MHC class I transgenic mouse model of myositis.
45. Vattemi G, Engel WK, McFerrin J, Askanas V. Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am J Pathol 2004; 164:1-7. This study demonstrates that the endoplasmic reticulum chaperone (calnexin, calreticulin, GRP94, GRP78, and endoplasmic reticulum p72) expression is increased in sporadic inclusion body myositis muscle, and these chaperones are associated with amyloid-β precursor protein.
46. Nakanishi K, Sudo T, Morishima N. Endoplasmic reticulum stress signaling transmitted by ATF6 mediates apoptosis during muscle development. J Cell Biol 2005; 169:555-560. This study shows that endoplasmic reticulum stress is up-regulated during nonpathological conditions such as myoblast differentiation.
47. Casciola-Rosen L, Nagaraju K, Plotz P, et al. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 2005; 201:591-601. This study demonstrated that autoantigens are highly expressed in regenerating muscle cells. These cells may be the likely targets of cytotoxic T-cell attack and source of autoantigens in myositis.
48. Casciola-Rosen L, Andrade F, Ulanet D, et al. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999; 190:815-826.
49. Mizuno K, Yachie A, Nagaoki S, et al. Oligoclonal expansion of circulating and tissue-infiltrating CD8+ T cells with killer/effector phenotypes in juvenile dermatomyositis syndrome. Clin Exp Immunol 2004; 137:187-194.
50. Skov S. Intracellular signal transduction mediated by ligation of MHC class I molecules. Tissue Antigens 1998; 51:215-223.
51. Pedersen AE, Bregenholt S, Johansen B, et al. MHC-1-induced apoptosis in human B-lymphoma cells is dependent on protein tyrosine and serine/threonine kinases. Exp Cell Res 1999; 251:128-134.
52. Due C, Simonsen M, Olsson L. The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biological functions of histocompatibility antigens. Proc Natl Acad Sci U S A 1986; 83:6007-6011.
53. Edidin M, Reiland J. Dynamic measurements of the associations between class I MHC antigens and insulin receptors. Mol Immunol 1990; 27:1313-1317.
54. Ramalingam TS, Chakrabarti A, Edidin M. Interaction of class I human leukocyte antigen (HLA-1) molecules with insulin receptors and its effect on the insulin-signaling cascade. Mol Biol Cell 1997; 8:2463-2474.